Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

London Seed Capital

Dec 2007
The London Seed Capital investment fund, the London Business Angels and the Catapult Venture Managers have awarded Michelson Diagnostics Ltd. of Orpington, UK, £600,000 of early-stage funding to pursue in vivo clinical trials of real-time cancer imaging technology. The project aims to enable faster and more accurate cancer surgeries. With the technology, the company expects that surgeons will be able to see a tumor’s size and location, assess its margin and spread, and create better outcomes.

Biophotonicsimaging technologyLondon Seed CapitalNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,
x Subscribe to BioPhotonics magazine - FREE!